BDBM25020 3-[7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl]phenol::thieno[3,2-d]pyrimidine derivative, 12
SMILES: Cc1csc2c(nc(nc12)-c1cccc(O)c1)N1CCOCC1
InChI Key: InChIKey=GQNBJVKYFWNUJB-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p110α/p85α (Homo sapiens (Human)) | BDBM25020 (3-[7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimid...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 21 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma | Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... | J Med Chem 51: 5522-32 (2008) Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 | |||||||||||
More data for this Ligand-Target Pair |